Skip to main content

Want a detailed portfolio tracker?

Cg Oncology (CGON) P/E (2024 - 2026)

Cg Oncology (CGON) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM Cg Oncology (CGON) P/E is -31.19. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cg Oncology (CGON)

YearP/EChange
2026-31.19+55.30%
2025-20.09-11.95%
2024-22.81N/A

Comparison Cg Oncology (CGON) P/E with competitors

Cg Oncology (CGON) P/E is -31.19.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.24%
FGENFibroGen Inc0.24-100.77%
CHRSCoherus Biosciences Inc0.85-102.72%
FBIOFortress Biotech Inc0.95-103.04%
ORMPOramed Pharmaceuticals Inc1.50-104.82%
AGENAgenus Inc3.01-109.65%
INVAInnoviva Inc3.15-110.11%
VXRTVaxart Inc3.55-111.38%
CRMDCorMedix Inc3.63-111.63%
CVACCureVac N.V.4.45-114.25%
GLPGGalapagos NV4.86-115.58%
SRPTSarepta Therapeutics Inc4.88-115.65%
ABEOAbeona Therapeutics Inc5.39-117.27%
ABUSArbutus Biopharma Corp5.60-117.94%
ZVRAZevra Therapeutics Inc5.89-118.87%
SPROSpero Therapeutics Inc6.23-119.97%
RIGLRigel Pharmaceuticals6.87-122.03%
SLXNSilexion Therapeutics Corp7.30-123.39%
OMEROmeros Corporation9.26-129.68%
AUPHAurinia Pharmaceuticals Inc9.58-130.73%
PLXProtalix BioTherapeutics Inc10.89-134.91%
ACADAcadia Pharmaceuticals Inc11.73-137.60%
TBPHTheravance Biopharma Inc12.26-139.31%
ADMAAdma Biologics Inc12.42-139.81%
HRMYHarmony Biosciences Holdings Inc13.82-144.30%
SABSSAB Biotherapeutics Inc14.14-145.32%
NAGENiagen Bioscience Inc14.82-147.50%
INCYIncyte Corp15.82-150.72%
REGNRegeneron Pharmaceuticals Inc15.86-150.83%
PBYIPuma Biotechnology Inc17.32-155.51%
CPRXCatalyst Pharmaceuticals Inc17.44-155.90%
EXELExelixis Inc17.54-156.22%
TGTXTG Therapeutics Inc18.97-160.80%
MDXGMimedx Group Inc20.55-165.88%
XOMAXOMA Royalty Corp22.87-173.33%
ARGXArgen X SE24.30-177.89%
CTMXCytomX Therapeutics Inc24.82-179.57%
XOMAOXOMA Royalty Corp25.34-181.25%
HALOHalozyme Therapeutics Inc25.62-182.14%
XOMAPXOMA Royalty Corp25.67-182.29%
VRTXVertex Pharmaceuticals Inc27.99-189.74%
RPRXRoyalty Pharma plc - Class A28.69-191.96%
SLNOSoleno Therapeutics Inc29.02-193.01%
ASNDAscendis Pharma A/S30.09-196.45%
LGNDLigand Pharmaceuticals Inc - Class B37.91-221.53%
APLSApellis Pharmaceuticals Inc39.02-225.09%
BMRNBiomarin Pharmaceutical Inc42.21-235.32%
KRYSKrystal Biotech Inc45.34-245.36%
ONCBeiGene Ltd69.54-322.93%
PHARPharming Group N.V.75.03-340.51%
TECHBio-Techne Corp101.96-426.85%
VCELVericel Corp109.92-452.37%
ALNYAlnylam Pharmaceuticals Inc117.96-478.16%
GMABGenmab140.29-549.73%
TLXTelix Pharmaceuticals Ltd162.15-619.81%
CORTCorcept Therapeutics Inc212.86-782.36%